Skip to content
  • Saturday, 15 August 2026
  • 12:54 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Insuring the Trip: An Underwriter on What It Will Take for Approved Psilocybin to Become a Real Business
Laboratory Automation & Robotics

Insuring the Trip: An Underwriter on What It Will Take for Approved Psilocybin to Become a Real Business

Lana Keisha Jul 23, 2026 0

More than five decades after the Controlled Substances Act, signed by President Richard Nixon in 1970, classified psilocybin as a…

Read More
Laboratory Automation & Robotics

Insuring the trip: an underwriter on what it will take for approved psilocybin can become a real business

Lana Keisha Jul 15, 2026 0

More than five decades after the Controlled Substances Act, signed by President Richard Nixon in 1970, categorized psilocybin as a…

Read More
Laboratory Automation & Robotics

Insuring the Trip: An Underwriter on What It Will Take for Approved Psilocybin to Become a Real Business

Lana Keisha Jul 8, 2026 0

The landscape of mental health treatment is on the cusp of a profound transformation, with psilocybin, a compound once relegated…

Read More
Pharmaceutical R&D

Talawar Therapeutics and JATT II Acquisition Complete Business Combination to Advance Novel Immunology Therapeutics

Teuku Ryan Jun 30, 2026 0

In a significant development poised to reshape the landscape of immunology therapeutics, New Jersey-based Talawar Therapeutics has officially merged with…

Read More
Laboratory Automation & Robotics

Insuring the trip: an underwriter on what it will take for approved psilocybin can become a real business

Lana Keisha Jun 30, 2026 0

More than five decades after the Controlled Substances Act, signed by President Richard Nixon in 1970, categorized psilocybin as a…

Read More
Data Science & Bioinformatics

Unlocking Business Foresight: How SciPy Transforms ‘What-If’ Scenario Planning with Advanced Statistical Simulation

Evan Lee Salim May 27, 2026 0

In an era defined by rapid change and unprecedented uncertainty, businesses are increasingly challenged to anticipate future outcomes, assess risks,…

Read More
Data Science & Bioinformatics

Advanced SQL Window Functions Revolutionize Data Analysis and Business Intelligence

Evan Lee Salim May 21, 2026 0

In an increasingly data-driven world, the ability to extract nuanced insights from vast datasets is paramount for business success. While…

Read More
Data Science & Bioinformatics

Unmasking the Hidden Failures: Why Most A/B Tests Fall Short in Delivering Real Business Value

Evan Lee Salim Apr 29, 2026 0

A common scenario plays out in countless product development cycles: a new feature, a design tweak, or a pricing model…

Read More
Pharmaceutical R&D

Merck KGaA Acquires JSR Life Sciences’ Chromatography Business to Bolster Biopharmaceutical Purification Capabilities

Teuku Ryan Apr 3, 2026 0

Germany-based Merck KGaA, a leading science and technology company, has officially completed its previously announced acquisition of the chromatography business…

Read More
Molecular Mapping of Bone Marrow Remodeling Reveals Early Inflammatory Drivers of Blood Cancer and Myelodysplastic SyndromeThe Epoch of Giants: Unraveling the Mystery of Earth’s Colossal InsectsCave of Whispers: Ancient Owl’s Larder Becomes Bee Nursery, Unveiling Remarkable Paleontological DiscoveryScientists Identify New Brain Drainage Control Point Using Advanced NASA-Developed Imaging Technology
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ